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Abstract:
Background—Activation of innate pattern recognition receptors promotes CD4+ T cell-mediated 
autoimmune myocarditis and subsequent inflammatory cardiomyopathy. Mechanisms, which 
counter-regulate exaggerated heart-specific autoimmunity are poorly understood. 
Methods and Results—Experimental Autoimmune Myocarditis (EAM) was induced in BALB/c 
mice by immunization with alpha-myosin heavy chain peptide (ĮMyHC) and complete Freund’s 
adjuvant (CFA). Together with IFN-J, heat-killed M. tuberculosis (Mtbhk), an essential 
component of CFA, converted CD11bhiCD11c– monocytes into TNFD- and nitric oxide synthase 
2 (NOS2)-producing dendritic cells (TipDCs). Mtbhk stimulated NOS2 production via Toll-like 
receptor (TLR)2-mediated NF-NB activation. TipDCs limited antigen-specific T cell expansion 
through NOS2-dependent nitric oxide production. Moreover, TipDCs promoted NOS2 
production in hematopoietic and stromal cells in a paracrine manner. Consequently, NOS2 
production by both, radiosensitive hematopoietic and radioresistant stromal cells prevented 
exacerbation of autoimmune myocarditis in vivo. 
Conclusions—Innate TLR2 stimulation promotes formation of regulatory TipDCs, which 
confine autoreactive T cell responses in EAM via nitric oxide. Therefore, activation of innate 
pattern recognition receptors is not only critical for disease induction, but also for counter-
regulatory mechanisms, protecting the heart from exaggerated autoimmunity. 
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Introduction 
Inflammatory dilated cardiomyopathy refers to an end stage heart failure phenotype, which often 
results from myocarditis. Clinical observations and animal experiments suggest that infection-
triggered autoimmunity plays an important role in myocarditis development and its progression 
to inflammatory dilated cardiomyopathy. Autoimmunity develops as a result of a breakdown in 
immunological tolerance leading to the activation of self-reactive T lymphocytes. Heart-specific 
autoimmunity is a consequence of the lack of T cell tolerance to heart-specific alpha-myosin 
heavy chain (ĮMyHC) in mice and in humans1,2. Activation of pattern recognition receptors on 
innate immune cells is widely believed to control the development of autoimmunity. Stimulation 
of Toll-like receptors (TLRs) on antigen presenting cells (APCs) represents an essential step in 
activation and differentiation of autoreactive, naïve T cells into pathogenic, disease-mediating T 
helper (Th) cells3,4. 
Commonly used animal models of autoimmune diseases are based on the delivery of self-
antigen together with complete Freund’s adjuvant (CFA) containing heat-killed M. tuberculosis
(Mtbhk) as its active component. In experimental autoimmune myocarditis (EAM), administration 
of alpha-myosin heavy chain (D-MyHC) peptide and CFA into BALB/c mice results in self-
limiting, CD4+ Th cell-mediated heart-specific inflammation5-9.  
IFN-Ȗ-producing Th1 cells represent a major subset of CD4+ T cells infiltrating the 
myocardium in EAM. However, the role of Th1 cells and IFN-Ȗ in pathogenesis of heart-specific 
autoimmunity is unclear. Mice lacking IFN-Ȗ or its receptor are highly susceptible to EAM 
induced with D-MyHC/CFA10-12. In contrast, in transgenic mouse model of spontaneous heart-
specific autoimmunity, IFN-Ȗ deficiency results in reduced myocarditis2. 
Nitric oxide synthase (NOS)2 represents an inducible isoform of NOS, which is absent in 
 by guest on November 22, 2013http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.112.000434 
4 
healthy myocardium, but has been clearly associated with tissue damage in patients with 
ischemic and nonischemic heart failures. In animal models, NOS2-producing cells have been 
reported to infiltrate the myocardium of D-MyHC/CFA immunized mice10 and upon infection 
with Coxsackievirus13 or T. cruzi14. In EAM, NOS2 production entirely depends on IFN-J10. 
NOS2-dependent nitric oxide has been shown to functionally eliminate heart-specific 
infections15,16, however its definitive role in the regulation of infection triggered heart-specific 
autoimmunity remains elusive. 
NOS2 is produced by various cell types including macrophages, activated monocytes, 
stromal fibroblastic and endothelial cells. TNFD- and iNOS-producing dendritic cells (TipDCs) 
represent another cell subset, which is capable to produce nitric oxide17,18. TipDCs originate 
from monocytes and therefore belong to a subset of monocyte-derived DCs. In contrast to 
conventional DCs, monocyte-derived DCs readily accumulate during infections and 
inflammation19. Both, conventional and monocyte-derived DCs express CD11c, MHC class II 
and are effective antigen presenters, but they can be distinguished by CD64 antigen expression19. 
Monocyte-derived TipDCs were reported to mediate the innate immune defence against bacterial 
infections17. Their role in the regulation of adaptive immune responses remains unclear.  
Here, we show how TLR2 activation together with IFN-J signalling converts monocytes 
into TipDCs, which limit T cell expansion and EAM development through nitric oxide. Our 
study reveals a novel principle of how cooperation of innate and adaptive mechanisms confines 
autoreactive heart-specific T cell responses. 
 
Materials and Methods 
Mice Balb/C mice (n=86) and Rag2í/í (n=39), Ifngí/í (n=15), Ifngr1í/í (n=9), Myd88í/í (n=4),
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Nos2í/í (n=44) and DO11.10-tg  (n=20) mice on Balb/C background were described 
previously7,10,11,20,21. Rag2í/íIfngr1í/í mice (n=15) were created by crossing Rag2í/í and Ifngr1í/í 
mice. In the respective in vitro experiments, cells were isolated from C57BL/6 mice (n=8) and 
Tlr2í/í (n=12), CD45.1-tg, (n=4) OT-II-tg (n=8) and Nos2í/í (n=4) mice on C57BL/6 background 
(all originally Jackson Laboratory). Animal experiments were performed in accordance with the 
Swiss federal law and were approved by the local authorities.
EAM induction 
To induce EAM mice were injected subcutaneously with 150 μg of D-MyHC (Ac-
RSLKLMATLFSTYASADR-OH; Caslo) peptide emulsified 1:1 with Complete Freund's 
Adjuvant (CFA, Difco) on days 0 and 7. In the respective experiments mice were injected with 
150 μg of D-MyHC peptide emulsified 1:1 with Incomplete Freund's Adjuvant (IFA, Difco). 
Chimeric mice
Bone marrow chimeras: 6-8 week old mice were lethally irradiated with two doses of 6.5 Gy as 
described and transplanted with total of 2x107 crude donor bone marrow and used 6 weeks after 
bone marrow reconstitution. Rag2í/í chimeras: 6-8 week old Rag2í/í or Rag2í/íIfngr1í/í mice 
received total of 107 naïve splenocytes and were used 3 weeks after cell transfer. 
Histopathology and Immunocytochemistry 
Tissues were fixed in formalin or HOPE (DCS-Diagnostic) and embedded in paraffin. Antigen 
retrieval procedure was performed using ER2 buffer (Leica) and sections were stained with rat 
anti-mouse CD45 (BD Bioscience), rabbit anti-mouse CD3 (Neomarkers), rabbit anti-NOS2 
(Millipore) and rabbit anti-rat IgG (Abcam) antibodies and the Bond Polymer Refine Detection 
kit using the BOND-MAX system (both Leica). Immunopositive cells were quantified using 
analySIS FIVE software (Olympus). For NF-NB p65 translocation, cells were stimulated for 30 
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min, fixed with 4% paraformaldehyede, permeabilized with 0.5% saponin (both Sigma) and 
stained with rabbit anti-NF-NB p65 (Abcam) and AlexaFluor488 anti-rabbit IgG (Invitrogen).  
[3H]-thymidine proliferation assay
CD4+ T cell magnetic beads (Miltenyi) were used to purify CD4+ T cells. CD4-negative 
population was used as APCs. A total of 5x104 CD4+ T cells co-cultured with 105 irradiated (25 
Gy) syngeneic APCs were re-stimulated for 48h in the presence of serial dilutions of the D-
MyHC peptide. Proliferation was assessed by measuring [3H]-thymidine incorporation during 
the last 8-16 hours. 
Flow cytometry and FACS  
Single cell suspensions were prepared from digested hearts treated with 0.2 mg/mL Liberase 
(Roche) for 45 min, lymph nodes treated with 3 mg/mL Collagenase D and 1 mg/mL DNAse 
(both Sigma) for 30 min and cultured cells using 70μm and 40μm cell strainers. Cells were 
incubated with the appropriate combination of fluorochrome-conjugated antibodies (available in 
the supplemental material). Samples were analysed with the FACSCanto analyser (BD 
Bioscience) and FlowJo software (Tree Star). Proliferation index (number of divisions of 
dividing cells) of CFSE-labeled cells was computed using FlowJo software. In the respective 
experiments, cells were sorted with FACSAria III (BD Bioscience). 
ELISA
Protein levels in supernatants were measured using mouse NOS2 (EIAab) and mouse TNFD (BD 
Bioscience) ELISA kits. 
Quantitative RT-PCR 
RNA was isolated with RNeasy Plus Kits (Qiagen) and cDNA was amplified using the Power 
SYBR Green PCR Master Mix (Applied Biosystems). Nos2 was detected using 5’-
 by guest on November 22, 2013http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.112.000434 
7 
cagctgggctgtacaaacctt-3’and 5’-tgaatgtgatgtttgcttcgg-3’ oligonucleotides. Gapdh levels were 
used for normalization. 
Nitric oxide measurement  
Concentrations of nitrite (NO2-) levels reflecting NO production were measured using the Griess 
Reagent System (Promega). 
Statistics
Normally distributed data were analysed by unpaired, two-tailed Student’s t-test and by one-way 
ANOVA followed by Bonferroni post-hoc test. All analyses were computed using GraphPad 
Prism 5 software. Differences were considered as statistically significant for p<0.05 (for multiple 
comparisons adjusted with the Bonferroni correction). 
Cell cultures 
Description of cell cultures is available in the supplemental material
Results
IFN-J signalling on non-lymphocytes limits T cell expansion in EAM  
Previous studies reported that IFN-J- and IFN-JR-deficient mice immunized with D-MyHC/CFA 
developed exacerbated myocarditis, post-inflammatory fibrosis and cardiac dysfunction10-12 
indicating that IFN-J priming, expansion, and/or differentiation of Th cells in EAM. Indeed, in 
hearts of IFN-J deficient (Ifng–/–) mice we observed an increased number of CD45+ cells (Fig.
1A) and CD3+ T lymphocytes (Fig. 1B), which peaked at day 16 of EAM. Restimulation of 
wild-type or Ifng–/– CD4+ T splenocytes with D-MyHC peptide in the presence of wild-type or 
Ifngr1–/– APCs showed that IFN-J production by T cells suppressed their proliferation indirectly 
through IFN-JR signalling in APCs (Fig 1C,D). These data suggest that exaggerated 
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autoimmunity of Ifng–/– mice is not due to intrinsic CD4+ T cell hyperproliferation. 
To verify this finding in vivo, we used a model of Rag2–/– mice (lacking T and B cells) injected 
with donor naïve splenocytes, which restored T and B subsets in Rag2–/– mice, but did not 
contribute to other hematopoietic compartments (Supplemental Fig. 1). Accordingly, we 
generated mixed chimera by adoptive transfer of a mixture of CD45.1+wild-type and 
CD45.2+Ifngr1–/– splenocytes into Rag2–/– mice 3 weeks prior to D-MyHC/CFA immunization. 
In these mice all CD3+CD4+ T cells derived from donor splenocytes. At day 16 of EAM, we 
observed unchanged CD45.1+:CD45.2+ T cell ratio in the spleen and inflamed hearts (Fig. 1E) 
indicating comparable expansion of autoimmune D-MyHC-specific wild-type and Ifngr1–/– CD4+
T cells. Moreover, Rag2–/– mice reconstituted with either wild-type or Ifngr1–/– cells showed 
comparable cardiac infiltrations with inflammatory CD45+ (Fig. 1F) and CD3+ (Fig. 1G) cells 
after D-MyHC/CFA immunization. In contrast, increased myocarditis was observed in Rag2–/–
Ifngr1–/– relative to Rag2–/– mice reconstituted with wild-type splenocytes prior immunization 
(Fig. 1H,I). Thus, our results unequivocally demonstrate that IFN-JR-signalling in the non-
lymphocytic compartment controls T cell expansion in D-MyHC/CFA immunized mice. 
Heat-killed M. tuberculosis activates TLR2 to induce IFN-J-dependent nitric oxide 
production 
Next, we studied how IFN-J regulates T cell expansion in the immune system. DO11.10-tg and 
OT-II-tg mice express transgenic T cell receptor recognizing a peptide from chicken ovalbumin 
(OVA). We isolated CD4+ T cells from DO11.10-tg mice and injected them into Rag2–/– or 
Rag2–/–Ifngr1–/– mice treated with IFA or CFA with or without OVA peptide. In agreement with 
the data above, DO11.10-tg CD4+ T cells showed much greater antigen-specific proliferation in 
the spleen of Rag2–/–Ifngr1–/– compared to Rag2–/– mice (Fig. 2A). Notably, even antigen 
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unspecific proliferation was enhanced in Rag2–/–Ifngr1–/– mice treated with CFA. 
CFA, in contrast to IFA, contains heat-killed Mycobacterium tuberculosis (Mtbhk). To better 
understand the role of Mtbhk in T cell response, we isolated splenocytes from Rag2–/– and Rag2–/–
Ifngr1–/– mice and co-cultured them with CD4+ T cells from DO11.10-tg mouse in the presence 
or absence of Mtbhk and OVA peptide. Interestingly, Mtbhk potently inhibited CD4+ T cell 
proliferation, which was dependent on intact IFN-JR-signalling in APCs (Fig. 2B). IFN-J is 
known to regulate several metabolic pathways including arginine metabolism and tryptophan 
catabolism controlling T cell responses. L-NAME, a competitive inhibitor of all NOS isoforms, 
greatly enhanced CD4+ T cell proliferation in the presence of Rag2–/– (Fig. 2C) but not of Rag2–
/–Ifngr1–/– (Fig. 2E) splenic APCs, while no differences were observed by inhibition of arginase-
1 and indoleamine 2,3-dioxygenase using the inhibitors Nor-NOHA and 1-methyl-tryptophan, 
respectively. Accordingly, co-cultures of CD4+ T cells and IFN-JR-competent splenocytes in the 
presence of L-NAME, but not Nor-NOHA or 1-methyl-tryptophan, revealed reduced nitrate 
levels reflecting reduced nitric oxide production (Fig. 2D,F). These results strongly suggest that 
T cell proliferation is suppressed via IFN-JR induced nitric oxide production by splenocytes. 
Consistently, we observed elevated nitrate levels in supernatants of proliferating CD4+ T cells in 
the presence of IFN-JR-sufficient, but not IFN-JR-deficient splenocytes, (Fig. 2G). Importantly, 
while signalling from proliferating T cells was sufficient to induce nitric oxide production, the 
addition of Mtbhk greatly enhanced it. 
Furthermore, bacterial lipoproteins such as Pam3CSK4 and FSL-1 potently inhibited 
CD4+ T cell proliferation and boosted nitric oxide production. In contrast, microbial nucleic 
acids such as Poly(I:C) or ODN1826 enhanced CD4+ T cell proliferation and reduced nitrate 
levels (Supplemental Fig. 2). 
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 Culture of Rag2–/– and Rag2–/–Ifngr1–/– splenocytes in the absence of T cells showed that 
stimulation with both IFN-J and Mtbhk was essential for up-regulation of Nos2 transcripts (Fig. 
2H), detectable NOS2 protein (Fig. 2I) and elevated nitrate levels (Fig. 2J) in the supernatant. 
Taken together these data suggest that stimulation of myeloid cells with IFN-J together with 
Mtbhk restrains CD4+ T cell proliferation via nitric oxide production. 
M. tuberculosis is recognized by immune cells primarily via TLR2, which induces the 
NF-NB signalling pathway. Using NF-NB specific reporter cells, we showed that Mtbhk, as well 
as native membrane vesicles (MV) produced by M. tuberculosis (Mtb MV) used TLR2 to 
activate NF-NB (Fig. 3A,B). As expected, TNFD activated the NF-NB pathway TLR2 
independently (Fig. 3A,B). Mtbhk or Mtb MV treatment of macrophages also induced nuclear 
translocation of NF-NB p65 (Fig. 3C). Furthermore, macrophages treated with Mtbhk in the 
presence of IFN-J showed TLR2-dependent nitric oxide (Fig. 3D) and TNFD (Fig. 3E) 
production. 
Next, we pre-treated Rag2–/– splenocytes with the irreversible NF-NB inhibitor Bay 11-
7082 (Bay) and stimulated them with Mtbhk and IFN-J. Bay completely prevented Nos2 up-
regulation (Fig. 3F) and nitrate oxide production (Fig. 3G). Furthermore, Rag2–/– splenocytes 
pretreated with Bay were unable to inhibit T cell proliferation, consistent with the lack of nitric 
oxide production (Fig. 3H,I). Our data demonstrate that Mtbhk requires TLR2 to induce NF-NB-
dependent nitric oxide production. 
M. tuberculosis antigens in cooperation with IFN-J convert monocytes into nitric oxide-
producing dendritic cells 
So far, it was unclear which cells produced nitric oxide in response to IFN-J and Mtbhk 
stimulation. Analysis of intracellular NOS2 in Rag2–/– splenocytes pointed to CD11bhiCD11c+ 
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cells as major nitric oxide producers (Fig. 4A). CD11bhiCD11c+ cells, however, are present in 
low numbers only in spleens and LNs of naïve mice (Fig. 4B). We found that they developed 
readily from CD11bhiCD11c– monocytes, when exposed to Mtbhk or IFN-J (Fig. 4C). In fact, 
stimulation of sorted CD11bhiCD11c– monocytes with IFN-J or Mtbhk induced expression of 
CD11c and CD64, but co-stimulation with IFN-J and Mtbhk or TNFD was required to boost 
NOS2 (Fig. 4C) and nitric oxide production (Fig. 4D). Notably, IFN-J and Mtbhk exerted distinct 
activities on CD11bhiCD11c– monocytes up-regulating MHC class II (Fig. 4C) and TNFD 
production respectively (Fig. 4E). Our data showed that, Mtbhk and IFN-Jconverted 
CD11bhiCD11c– monocytes into TNFD- and NOS2-producing DCs. This subset of DCs has been 
previously described and termed TipDCs17. 
Our findings showed that Mtbhk-stimulated TipDCs massively produce TNFD, which 
potentially could boost locally NOS2 production. As shown above, Mtbhk is specifically 
recognized by TLR2, and therefore stimulation with IFN-J and Mtbhk resulted in impaired NOS2 
production in CD11bhiCD11c– Tlr2–/– cells (Fig. 4F). Instead, co-culture with wild-type TipDCs 
boosted NOS2 production in Tlr2–/– cells (Fig. 4G). This result clearly indicates that Mtbhk-
activated TipDCs contribute to positive regulation of NOS2 in neighbouring cells. 
DCs are specialized in capturing, processing and presenting of antigens to T cells. We 
found that in contrast to CD11bhiCD11c– monocytes, naïve and Mtbhk/IFN-J-activated 
CD11bhiCD11c+ DCs effectively induce antigen-specific T cell proliferation (Fig. 5A). This 
result indicates that monocytes converting into DC phenotype acquire APC properties. 
So far, definitive evidence that nitric oxide produced by TipDCs limits T cell expansion is 
lacking. CD11bhiCD11c– cells with a disrupted Ifngr1 MyD88 or Tlr2 gene stimulated with IFN-
J and Mtbhk showed impaired Nos2 expression (Fig. 5B,F) and failed to produce nitric oxide (Fig. 
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5C,G) confirming that IFN-JR-signaling and Mtbhk-induced TLR2/MyD88 signalling was 
crucial for development of nitric oxide-producing TipDCs. Next, we co-cultured OVA-reactive 
CD4+ T cells with conventional DCs in the presence of CD11bhiCD11c– cells, OVA peptide and 
Mtbhk. We observed uncontrolled T cell proliferation (Fig. 5D,H) and reduced nitric oxide (Fig.
5E,I) in the presence of Nos2–/–, Ifngr1–/–, MyD88–/– or Tlr2–/– monocyte-derived DCs. This 
result clearly demonstrates that NOS2 production defines the regulatory role of monocyte-
derived DCs. 
TipDCs promote nitric oxide production in stromal fibroblasts  
Stromal cells represent another important source of NOS2-derived nitric oxide. We used the 
nitric oxide-producing pLN2 cell line established from LN fibroblasts to address whether M.
tuberculosis antigens affect nitric oxide production in this cell type. However, stimulation with 
Pam3CSK4, Mtbhk or Mtb MV failed to induce NF-NB p65 nuclear translocation on pLN2 cells, 
probably due to insufficient TLR2 expression (Fig. 6A,B). Instead, TNFD induced translocation 
of NF-kB p65 into nucleus (Fig. 6A,B) and in cooperation with IFN-J promoted Nos2 expression 
and nitric oxide production in these fibroblasts (Fig. 6C,D). Accordingly, addition of Mtbhk or 
Mtb MV to co-cultures of pLN2 with conventional DCs and OT-II-tg CD4+ T cells failed to 
affect antigen-specific T cell proliferation and nitric oxide levels (Fig. 6E,F). Thus, these results 
demonstrate that TLR2 is required for Mtbhk-induced nitric oxide production not only in myeloid, 
but also in stromal cells. 
We demonstrated that Mtbhk induced production of cytokines, such as TNFD, which 
could stimulate NOS2 production in monocyte-derived DCs and in pLN2 cells. To analyze, 
whether TipDCs activated with Mtbhk can stimulate NOS2 production in stromal cells, we sorted 
CD11bhiCD11c– from Nos2–/– splenocytes and co-cultured them with pLN2 cells in the presence 
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or absence of Mtbhk. Indeed, addition of Mtbhk induced nitric oxide levels in co-cultures (Fig.
6G). Giving that pLN2 cell fail to respond to Mtbhk, these results indicate that Mtbhk-activated 
TipDCs can induce nitric oxide production in stromal cells. 
Nitric oxide from TipDCs or stromal cells limits EAM progression 
So far, our data demonstrated that Mtbhk induced NOS2 and nitric oxide production in vitro. To 
analyze its role in EAM development, we subcutaneously injected mice with D-MyHC/CFA into 
the right groin and with D-MyHC/IFA into the left groin and analyzed 5 days later inguinal 
lymph nodes (iLNs, Fig. 7A). At the side of D-MyHC/CFA injection, iLNs were enlarged and 
contained more NOS2-producing cells (Fig. 7B). Furthermore, CFA-primed iLNs were 
infiltrated by higher number of CD11bhiCD11c+ cells (Fig. 7C), which showed enhanced NOS2 
levels (Fig. 7D). Instead, stromal cells from the CFA- and IFA-primed iLNs showed comparable 
NOS2 production (Fig. 7E). These results suggest that in the EAM model, Mtbhk promotes 
formation of TipDCs at the site of antigen delivery. 
To address a direct role of NOS2 in EAM, we immunized BALB/c and Nos2–/– mice with 
D-MyHC/CFA. We observed enhanced myocarditis (Fig. 8A,B) and an increased number of 
infiltrating CD45+ cells (Fig. 8C) and CD3+ T lymphocytes (Fig. 8D) in hearts of Nos2–/– mice at 
day 16 of EAM. We found that, both CD11bhiCD11c– monocytes and CD11bhiCD11c+ 
monocyte-derived DCs heavily infiltrate the myocardium in EAM at this time point. As expected, 
NOS2 was mainly identified in the CD11bhiCD11c+ population that also expressed MHC class II 
and CD64 (Fig. 8E) indicating a TipDC phenotype. Furthermore, restimulation of wild-type and 
Nos2–/– CD4+ T cells with D-MyHC peptide presented by wild-type or Nos2–/– APCs showed that 
absence of NOS2 in APCs, but not in CD4+ T cells, resulted in enhanced D-MyHC-specific T 
cell proliferation (Supplemental Fig. 3). 
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To verify that nitric oxide produced by inflammatory TipDCs prevented uncontrolled 
myocarditis, we generated criss-cross bone marrow chimeras by injection of the whole bone 
marrow from wild-type or Nos2–/– mice to lethally irradiated wild-type and Nos2–/– recipients. 6 
weeks later, we immunized the bone marrow chimeric mice with D-MyHC/CFA to induce EAM. 
Interestingly, we found elevated numbers of infiltrating CD45+ cells (Fig. 8F) and CD3+ T 
lymphocytes (Fig. 8G) only in Nos2–/–->Nos2–/– chimeras suggesting that nitric oxide production 
by either radiosensitive hematopoietic cells or by radioresistant non-hematopoietic stromal cells 
was sufficient to prevent exacerbated myocarditis. Indeed, immunohistochemistry of NOS2 on 
heart tissue sections from the bone marrow chimeras showed NOS2-positive cells in both 
hematopoietic (wild-type->Nos2–/–) and non-hematopoietic compartments (Nos2–/–->wild-type, 
Fig. 8H). As illustrated above, TipDCs represent major NOS2 producers in hematopoietic 
inflammatory fraction in EAM. Heart tissue analysis of Nos2–/–->wild-type chimeras showed that 
NOS2 was expressed by gp38-positive fibroblasts in the inflamed heart (Supplemental Fig. 4). 
Importantly, NOS2-producing radioresistant stromal cells were only found in the inflamed areas 
indicating local induction, and NOS2 was undetectable in healthy hearts. 
 
Discussion 
In myocarditis, IFN-Ȗ-producing Th1 cells infiltrate the myocardium, but the role of IFN-Ȗ 
remains unclear. IFN-Ȗ is a proinflammatory cytokine, which when overexpressed induces 
chronic myocarditis22. Furthermore, in transgenic model of spontaneous autoimmune 
myocarditis, IFN-Ȗ was recognized to promote inflammation2. On the other hand, IFN-Ȗ clearly 
attenuates myocarditis induced with D-MyHC/CFA10-12 or triggered by viral23 or parasitic24 
infections. Our data showing increased EAM susceptibility of Rag2–/–Ifngr1–/– chimeric mice 
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reconstituted with wild-type lymphocytes clearly demonstrated that lack of IFN-J receptor on 
non-T cells is responsible for exacerbated T cell expansion and myocarditis in the D-MyHC/CFA 
model. We identified the well-known IFN-J-dependent nitric oxide production as the key 
mechanism limiting autoreactive T cell proliferation in EAM.  
Effective NOS2-dependent nitric oxide production requires co-activation of the NF-NB 
pathway with TLR agonists or pro-inflammatory cytokines, such as TNFD. Activated T cells 
produce both co-signals (IFN-J, and TNFD) required for Nos2 up-regulation. Here, we showed 
that in addition to T cells, direct innate signalling on myeloid cells remarkably contributes to 
nitric oxide production. Our data demonstrate that M. tuberculosis antigens promoted conversion 
of CD11bhiCD11c– monocytes into nitric oxide-producing TipDCs. Importantly, TipDCs 
represent a subset of monocyte-derived DCs, which corresponds to classically activated 
macrophages and is distinct from conventional DCs19,25. In line with previous findings19,25, we 
showed that TipDCs massively accumulate during inflammation. A previous report pointed to a 
proinflammatory role of monocyte-derived DCs in autoimmunity26. Indeed, our data show that 
monocyte-derived DCs express MHC class II and therefore can engage and also potentially 
expand autoreactive CD4+ T cells. Importantly, our data clearly show that nitric oxide produced 
by TipDCs efficiently suppresses T cell expansion. Therefore, it is important to distinguish 
TipDCs from other NOS2-negative monocyte-derived DCs because of the opposing effects of 
these two DC subsets on T cell proliferation. Although the ultimate role of monocyte-derived 
DCs and TipDCs in autoimmunity has not been fully elucidated yet, our data clearly demonstrate 
that NOS2 production defines their regulatory function. 
Subcutaneous delivery of self-peptides together with CFA represents the most common 
immunization procedure in rodent models of autoimmune diseases. The presence of Mtbhk in 
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CFA is critical for the induction of pathogenic T cell response in these models3. The innate 
immune response apparently plays a dual role in regulating adaptive autoimmunity. On one hand, 
it promotes development of pathogenic Th cells and inflammation. On the other hand, together 
with IFN-J, it prevents uncontrolled expansion of activated T cells. 
Experiments with bone-marrow chimeras showed that in EAM both hematopoietic and 
stromal cells produced functional NOS2. We showed that Mtbhk-activated TipDCs promote nitric 
oxide production in stromal fibroblasts, which failed to directly respond to Mtbhk due to absence 
of TLR2 expression. Thus we propose that both, T cells and TipDCs regulate NOS2 production 
in stromal cells. Our data suggest that this mechanism is not limited to the lymphatic system. In 
fact, T cells and TipDCs infiltrate the heart in EAM, and NOS2 is detected in gp38-positive 
cardiac fibroblasts only within the inflamed myocardium. Of note, paracrine NOS2 regulation by 
TipDCs is not restricted to stromal cells only. Our data clearly show that Mtbhk-activated TipDCs 
promote NOS2 production also in other monocyte-derived cells. Thus, Mtbhk triggers several 
cellular mechanisms of NOS2 up-regulation, which consequently all negatively regulate T cell 
responses. 
Taken together, we demonstrated that innate immune signalling, which initially triggers 
autoimmune responses, also activates counter-regulatory NOS2-dependent mechanisms 
protecting from exaggerated T cell responses. Our observation might explain the fact, that we 
rarely observe massive T cell responses in patients with myocarditis. Counter-regulatory 
mechanisms, however, might protect from fulminant myocarditis at the cost of chronic, 
smoldering inflammation promoting pathological remodelling and inflammatory cardiomyopathy 
development. Indeed, innate signalling has been recognized to promote phenotype of dilated 
cardiomyopathy in EAM20, and IFN-J is known to regulate Th2 and Th17 responses, which were 
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reported to modulate postinflammatory myocardial remodelling27. Further studies are needed to 
elucidate a potential role for IFN-J and nitric oxide mediated down-regulation of heart-specific 
autoimmunity in the human system.  
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Figure Legends: 
Figure 1. IFN-J signalling on non-lymphocytes controls EAM development. (A,B) Shown is the 
quantification of CD45+ (A) and CD3+ (B) immunopositive cells on heart sections of D-
MyHC/CFA immunized wild-type (white) and Ifng–/– (black) mice at the indicated stages of 
EAM. (C,D) Splenic CD4+ T cells from wild-type (white) and Ifng–/– (black) mice at day 21 of 
EAM were restimulated with D-MyHC peptide in the presence of wild-type (c) or Ifngr1–/– (D) 
APCs for 48h. Incorporation of [3H]-thymidine indicates cell proliferation. Mean values±SD, 
n=3, data are representative of 3-4 independent experiments. (E) Wild-type (CD45.1+) and 
Ifngr1–/– (CD45.2+) splenocytes were mixed and transferred into Rag2–/– mice. After 3 weeks, the 
mixed chimeric mice were immunized with D-MyHC/CFA. Flow cytometry analysis of CD45.1 
and CD45.2 alloantigens (right) gated on CD3+CD4+ T cells (left) shows donor cells used for 
injection (top) and splenocytes (middle) and heart inflammatory cells (bottom) of the mixed 
chimeras at day 16 of EAM. Numbers indicate percent of cells in the adjacent gates. 
Representative plots of 4-8 independent mice. (F,G) Quantification of CD45 (F) and CD3 (G) 
immunopositive cells on heart sections of D-MyHC/CFA immunized Rag2–/– mice reconstituted 
with wild-type (white diamonds) or Ifngr1–/– (black diamonds) splenocytes. (H,I) Quantification 
of CD45 (H) and CD3 (I) immunopositive cells on heart sections of D-MyHC/CFA immunized 
Rag2–/– (white triangles) and Rag2–/–Ifngr1–/– (black triangles) mice reconstituted with wild-type 
splenocytes. p values computed with Student’s t-test. 
Figure 2. Heat-killed M. tuberculosis suppresses T cell proliferation through IFN-JR-dependent 
nitric oxide. (A) OVA-specific CD4+ T cells (from DO11.10-tg mouse) were CFSE-labeled and 
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transferred to Rag2–/– and Rag2–/–Ifngr1–/– mice prior treatment with IFA or CFA in the absence 
and presence of OVA peptide. Mice were analysed 72h later. Histograms show CFSE-dilutions 
of an individual representative of indicated groups of mice (n=3-4). (B) Proliferation index 
(number of divisions of dividing cells) of CFSE-labeled DO11.10-tg CD4+ T cells (5x104) co-
cultured with Rag2–/– (white) or Rag2–/–Ifngr1–/– (black) splenocytes (2x105) in the presence or 
absence of 10 μg/mL heat-killed M. tuberculosis (Mtbhk) and 2 μg/mL OVA peptide. Data are 
representative of 3 independent experiments, mean values±SD, n=3, *p<0.05 (Student’s t-test). 
(C-F) Rag2–/– (white, C,D) and Rag2–/–Ifngr1–/– (black, E,F) splenocytes were co-cultured with 
CFSE-labeled DO11.10-tg CD4+ T cells (5x104) in the presence of Mtbhk and OVA peptide 
without (control) or with the following inhibitors:NȦ-nitro-L-arginine methyl ester 
hydrochloride (L-NAME, 1mM), 1-methyl-tryptophan (1-MT, 5μM) or NȦ-hydroxy-nor-
arginine (Nor-NOHA, 50μM). Proliferation of CFSE-labeled DO11.10-tg CD4+ T cells (C,E)
and nitrate levels in supernatants (D,F) were analyzed after 72h. Mean values±SD, *p<0.017 
versus control (Student’s t-test). (G) Nitrate levels in supernatants of Rag2–/– (white) or Rag2–/–
Ifngr1–/– (black) splenocytes and DO11.10-tg CD4+ T cells co-cultured in the presence or 
absence of Mtbhk and OVA peptide for 72h. (H-J) Rag2–/– (white) or Rag2–/–Ifngr1–/– (black) 
splenocytes (2x105) cultivated in the presence or absence of Mtbhk and IFN-J. Cells were 
analyzed for Nos2 mRNA (H) and supernatants for NOS2 (I) and nitrate (J) after 72h. Mean 
values±SD, *p<0.05 (Student’s t-test), n.d. - not detected 
 
Figure 3. NF-NB pathway controls NOS2-dependent nitric oxide production. (A,B) NF-NB 
activity measured in NF-NB reporter cells expressing TLR2 (HEK-Blue TLR2, a) or control 
(HEK-Blue Null1, B) unstimulated (control) and stimulated with 50 ng/mL TNFD, 1 μg/mL 
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Pam3CSK4, 10 μg/mL Mtbhk or 20 ng/mL Mtb membrane vesicles (MV). (C) Representative 
immunofluorescence of NF-NB p65 (green) in non-stimulated (control) and stimulated (30 min) 
wild-type (left) and Tlr2–/– (right) bone marrow-derived macrophages. DAPI (blue) was used to 
stain nuclei, magnification x200. (D,E) Wild-type (white) and Tlr2–/– (grey) bone marrow-
derived macrophages (5x105) were cultured in the presence (+) or absence (-) of IFN-J and 
stimulated with Pam3CSK4, Mtbhk or Mtb MV. Cell supernatants were analyzed for nitrate (D) 
and TNFD (E) after 72h. Mean values±SD, *p<0.05 (Student’s t-test). (F-I) Rag2–/– splenocytes 
(2x105) were pretreated (1h) with vehicle or irreversible NF-NB inhibitor Bay 11-7082 (Bay). 
(F,G) Pretreated cells were cultured in the presence of IFN-J without (control) or with Mtbhk and 
analyzed for Nos2 mRNA (F) and supernatants for nitrate (G) after 72h. (H,I) Pretreated cells 
were co-cultured with DO11.10-tg CD4+ T cells in the presence of OVA peptide without 
(control) or with Mtbhk. Proliferation of CFSE-labeled DO11.10-tg CD4+ T cells (H) and nitrate 
levels in supernatants (I) were analyzed after 72h. Mean values±SD, *p<0.05 (Student’s t-test) 
 
Figure 4. M. tuberculosis antigens induce formation of NOS2-producing monocyte-derived 
dendritic cells. (A) Representative flow cytometry analysis of intracellular NOS2 in Rag2–/– 
splenocytes cultivated in the absence (control) and presence of Mtbhk and/or IFN-J (as indicated 
on top of the diagrams) for 72h. NOS2-positive cells were analyzed for CD11b and CD11c 
(right). Numbers indicate percent of cells in the adjacent gates. FL-2 - empty channel. Data are 
representative of 3 independent experiments. (B) Representative flow cytometry dot plots of 
naïve splenocytes (left) and iLN cells (right) stained with anti-CD11c and anti-CD11b antibodies. 
Gated cells were sorted and used for further analysis. Value in gates indicates percentage. (C-E) 
Sorted splenic CD11bhiCD11c– cells (gating in B, 5x104) were cultured unstimulated (control) or 
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in the presence of 50 ng/mL IFN-J10 μg/mL Mtbhk, 20 ng/mL Mtb MV or 50 ng/mL TNFD as 
indicated, and were analyzed after 72h. Shown are representative dot plots of CD11b and CD11c 
expression and histograms of MHC class II, CD64 and intra-cellular NOS2  (C). Value shows 
percentage of double positive cells in the adjacent gate (dot plots). Isotype controls are shown in 
grey (histograms). Supernatants were analyzed for nitrate  (D) and TNFD  (E). Mean values±SD, 
n = 4, *p<0.0125 versus control (Student’s t-test). Data are representative of 3 independent 
experiments. (F,G) CD11bhiCD11c– splenocytes (gating in B, 5x104 cells) were sorted from 
wild-type (CD45.1+) and Tlr2–/– (CD45.2+) mice. Cells were cultured separately (F) or in co-
cultures (G) in the presence of IFN-J and Mtbhk for 72h. Intracellular NOS2 was analyzed by 
flow cytometry on CD45.1+ (wild-type, left) and CD45.2+ (Tlr2–/–, right) gated cells. Data are 
representative of 3 independent experiments. Isotype controls are shown in grey. 
 
Figure 5. Monocyte-derived dendritic cells induce and limit T cell proliferation. (A) Unactivated 
(-) or activated with IFN-Jand Mtbhk splenocytes were cultured in the presence of OVA peptide 
for 24h. Next, sorted CD11bhiCD11c– or CD11bhiCD11c+ cells (gating in Fig. 4B) were used as 
APCs (104) in co-cultures with CFSE-labeled DO11.10-tg CD4+ T cells (5x104) as indicated. 
Representative histograms show CFSE-dilutions of DO11.10-tg CD4+ T cells after 72h. (B-E) 
Sorted CD11bhiCD11c– cells (5x104) from the indicated mouse strains were cultured in the 
presence of IFN-J and Mtbhk for 72h and analyzed for Nos2 mRNA (B) and supernatants for 
nitrate (C). Sorted CD11bhiCD11c– cells (5x104) were co-cultured with conventional DCs (104) 
and CFSE-labeled DO11.10-tg CD4+ T cells in the presence of Mtbhk and OVA peptide. 
Proliferation index of DO11.10-tg CD4+ T cells (D) and nitrite levels in supernatant (E) were 
analyzed after 72h. Data are representative of 2 independent experiments. Mean values±SD, n = 
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3, *p<0.017 versus wild-type (Student’s t-test), n.a. - not analyzed. (F-I) Sorted splenic 
CD11bhiCD11c– cells (5x104) from wild-type (white) or Tlr2–/– (black) were cultured in the 
presence of IFN-J without (control) or with Mtbhk and analyzed for Nos2 mRNA (F) and 
supernatants for nitrate (G) after 72h. Sorted CD11bhiCD11c– cells (5x104) were co-cultured 
with conventional DCs (104) and CFSE-labeled OT-II-tg CD4+ T cells in the presence of OVA 
peptide without (control) or with Mtbhk. Proliferation index of OT-II-tg CD4+ T cells (H) and 
nitrite levels in supernatant (I) were analyzed after 72h. Data are representative of 2 independent 
experiments. Mean values±SD, n = 3-4, *p<0.05 (Student’s t-test). 
 
Figure 6. M. tuberculosis antigens fail to regulate nitric oxide production in pLN2 stromal 
fibroblasts. (A) Representative flow cytometry analysis of TLR2 in bone marrow macrophages 
(left) and pLN2 cells (right). Isotype controls are shown in grey. (B) Nuclear translocation of 
NF-NB p65 (green) in pLN2 cells. Cells were treated for 30 min without (control) or with 10 
ng/mL IFN-J, 50 ng/mL TNFD, 1 μg/mL Pam3CSK4, 10 μg/mL Mtbhk or 20 ng/mL Mtb MV. 
DAPI (blue) was used to stain nuclei, magnification x200. Data are representative of 3 
independent experiments. (C,D) pLN2 cells were cultured in the absence (control) or presence of 
IFN-J (+IFN-J) and without (white) or with TNFD(green), Mtbhk (black) or Mtb MV (red) for 
72h and analyzed for Nos2 mRNA (C) and supernatants for nitrate (D). Mean values±SD, n = 4, 
*p<0.017 versus controls (white, Student’s t-test). (E,F) Conventional DCs and OT-II-tg CFSE-
labeled CD4+ T cells were co-cultured without (-) or with (+) pLN2 cells in the absence (control) 
or presence of Mtbhk or Mtb MV. Proliferation index of OT-II-tg CD4+ T cells (E) and nitrite 
levels in supernatants (F) are shown. Mean values±SD, n = 3, *p<0.017 versus control +pLN2 
(Student’s t-test). Data are representative of 3 independent experiments. (G) Sorted 
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CD11bhiCD11c– splenocytes (gating in Fig. 4B) from Nos2–/– mice were co-cultured with pLN2 
cells in the presence of IFN-J (white) or IFN-J and Mtbhk (grey) for 72h and analyzed for nitrate 
in supernatants. Data are representative of 3 independent experiments. Mean values±SD, n = 3, 
*p<0.05 (Student’s t-test). 
 
Figure 7. Heat-killed M. tuberculosis in the adjuvant promotes formation of NOS2-positive 
monocyte-derived dendritic cells in EAM. Balb/c mice were subcutaneously immunized with D-
MyHC/CFA into the right groin and with D-MyHC/IFA into the left groin (A) and inguinal 
lymph nodes (iLNs) were analyzed at day 5. (B) Representative immunohistochemistry of NOS2 
(brown) in the indicated iLN (magnification x100). (C) Quantification of total CD11bhiCD11c+ 
cells isolated from the indicated iLN. Lines link iLNs from the same mouse. p value computed 
with paired t-test. (D,E) Representative flow cytometry analysis of intracellular NOS2 in 
CD11bhiCD11c+ cells (D) and in CD45–gp38+ stromal cells (E) from the indicated iLN. Arrows 
show gating strategy. Numbers indicate percent of cells in the adjacent gates. Isotype controls are 
shown in grey.
 
Figure 8. NOS2 produced by either hematopoietic or non-hematopoietic cells is sufficient to 
prevent exacerbated EAM. (A,B) Representative histology of heart sections of wild-type (A) and 
Nos2–/– (B) mice at day 16 of EAM. (C,D) Quantification of immunopositive cells for CD45 (C) 
and CD3 (D) antigens on heart sections of D-MyHC/CFA immunized wild-type (white) and 
Nos2–/– (black) mice at the indicated stages of EAM. p values computed with Student’s t-test. (E) 
Representative flow cytometry analysis of hearts from wild-type (top) and Nos2–/– (bottom) mice 
at day 16 of EAM. Arrows show gating strategy. Numbers indicate percent of cells in the 
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adjacent gates. Isotype controls are shown in grey. (F-H) Bone marrow chimeric mice were 
immunized with D-MyHC/CFA 6 weeks after lethal irradiation and bone marrow reconstitution. 
Shown are quantification of CD45 (F) and CD3 (G) immunopositive cells and the representative 
NOS2 immunohistochemistry (H, brown, magnification x100) in heart sections from the 
indicated bone marrow chimeras at day 16 of EAM. *p<0.05 versus Nos2–/–->Nos2–/– group 
(ANOVA followed by Bonferroni post-hoc test).  
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SUPPLEMENTAL MATERIAL 
 
Supplemental methods 
 
Cell culture Generations of bone marrow-derived macrophages1 and pLN stromal 
cells2 were described previously. Bone marrow-derived macrophages were stimulated 
at 106 cells/mL for 24h. Erythrocyte-lysed splenocytes were cultured at 106 cells/mL 
for 72h. FACSorted CD11bhiCD11c− cells were cultured at 5x105 cells/mL for 72h. 
pLN stromal cells were irradiated (1000 rad) and cultured at 5x104 cells/mL for 72h. 
Human TLR2/NF-κB/SEAP reporter HEK293 cells HEK-Blue TLR2 and NF-
kappaB/SEAP parental cell line HEK-Blue Null1 (both Invivogen) were cultured and 
analyzed according to manufacturer’s recommendations. Cells were cultured in RPMI 
supplemented with 10% fetal bovine serum, penicillin/streptomycin, β-
mercaptoethanol, sodium pyruvate and non-essential amino acids at 37ºC and 5% 
CO2, unless otherwise indicated. 
 
Co-cultures CD4 T cells were isolated from spleens using magnetic beads (Miltenyi 
Biotec) and labeled with 2.5 µM CFSE (7 min. at room temperature). 2x105 Rag2−/− 
and Rag2−/−Ifngr1−/− splenocytes were co-cultured with 5x104 CFSE-labeled CD4+ T 
cells and 2 µg/mL OVA323-339 peptide (Anaspec) in 0.25 mL culture medium and 
analyzed after 72h. 5x104 FACSorted CD11bhiCD11c− cells were co-cultured with 104 
FACSorted CD11bhiCD11c+ cells, 5x104 CFSE-labeled CD4+ T cells and 2 µg/mL 
OVA323-339 peptide in 0.2 mL culture medium and analyzed after 72h. In the 
respective experiments, 5x104 FACSorted CD11bhiCD11c− cells were co-cultured 
with 104 irradiated stromal cells for 72h. 
 
APC assay Splenocytes were cultured in the presence of 2 µg/mL OVA323-339 peptide 
with or without 10 µg/mL heat-killed M. tuberculosis and 10 ng/mL recombinant 
IFN-γ for 24h and FACSorted afterward. 104 sorted cells were co-cultured with 5x104 
CFSE-labeled CD4+ T cells in 0.25 mL culture medium and analyzed after 72h. 
 
Cell treatment Cells were treated with the following reagents: 10 µg/mL heat-killed 
M. tuberculosis H37Ra (Difco), 10-100 ng/mL recombinant IFN-γ, 50 ng/mL 
! - S2 -!
recombinant TNF-α (both Peprotech), 1 µg/mL Pam3CSK4, 108 cells/mL HKLM, 10 
µg/mL Poly(I:C)-LMW, 10 µg/mL Poly(I:C)-HMW, 0.1-1 µg/mL LPS, 1 µg/mL ST-
FLA, 1 µg/mL FSL-1, 1 µg/mL ssRNA, 5 µM ODN1826 (all Invivogen). Membrane 
vesicles produced by M. tuberculosis H37Ra were purified as described3 and used at 
50 ng/mL. Chemical inhibitors: 1 mM Nω-nitro-L-arginine methyl ester 
hydrochloride (L-NAME, Sigma), 5 µM 1-methyl-tryptophan (1-MT, Sigma) or 50 
µM Nω-hydroxy-nor-arginine (Nor-NOHA, Calbiochem), 10 µM Bay 11-7082 
(Sigma). Splenocytes pretreated with Bay 11-7082 for 1h at 37ºC were washed twice 
and resuspended in culture medium for further use. 
 
Flow cytometry and FACS 
The following antibodies were user in this study: anti-CD45 (clone 30-F11), anti-
CD11c (N418), anti-CD4 (GK1.5), anti-DO11.10-TCR (KJ1-26), anti-TLR2 (mT2.7, 
all eBioscience), anti-CD11b (M1/70), anti-I-A/I-E (2G9), anti-CD45.1 (A20), anti-
CD45.2 (104, all BD Bioscience), anti-CD3 (145-2C11), anti-CD4 (RM4-4), anti-
CD64 (X54-5/7.1, all Biolegend). 
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!Supplemental figure legends 
 
Supplemental figure 1. Donor splenocytes reconstitute T and B cell pools in Rag2–/– 
mice. 
The whole CD45.1+ splenocytes were injected into Rag2–/– (CD45.2+) mice. After 3 
weeks, chimeric mice were immunized with α-MyHC/CFA. Flow cytometry analysis 
of CD45.1 and CD45.2 alloantigens in CD4+ T cells (A), CD8+ T cells (B), B cells 
(C), non-T and non-B cells (D) in the peripheral blood and in heart inflammatory 
(CD45+) CD4+ T cells (E). Arrows show gating strategy. Numbers indicate percent of 
cells in the adjacent gates. Representative plots of 3 mice are shown. 
 
Supplemental figure 2. TLR agonists differentially regulate T cell proliferation and 
nitric oxide production. 
Rag2–/– (white) or Rag2–/–Ifngr1–/– (black) splenocytes were co-cultured with CFSE-
labeled DO11.10-tg CD4+ T cells in the presence of OVA peptide without (control) or 
with the indicated TLR agonists. Proliferation index of CFSE-labeled DO11.10-tg 
CD4+ T cells (A,C) and nitrate levels in supernatants (B,D) were analyzed after 72h. 
Data are representative of 2-5 independent experiments, n = 3, * p<0.05 versus 
control (Student’s t-test), n.d. - not detected 
 
Supplemental figure 3. NOS2 production by APCs limits α-MyHC-specific 
proliferation in EAM 
Splenocytes from wild-type (white) and Nos2–/– (black) mice at day 21 of EAM were 
sorted for CD4-positive T cells and CD4-negative APCs and restimulated with α-
MyHC peptide. (A) Co-cultures of wild-type (white diamonds) or Nos2–/– (black 
diamonds) CD4+ T cells with wild-type APCs. (B) Co-cultures of wild-type CD4+ T 
cells with wild-type (white triangles) or Nos2–/– (black triangles) APCs. Incorporation 
of [3H]-thymidine indicates cell proliferation. n = 6, data are representative of 2 
independent experiments 
 
Supplemental figure 4. Cardiac gp38-positive stromal cells produce NOS2 in EAM 
!Constitutive heart tissue sections of Nos2–/–->wild-type bone marrow chimeric mouse 
at day 16 of EAM stained for NOS2 (left) and gp38 (right). Arrows indicate the same 
region of two constitutive sections. Magnification x200. 
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